These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36678586)

  • 21. Intravitreal aflibercept efficacy in neovascular age-related macular degeneration with suboptimal response to anti-vascular endothelial growth factor-A therapy.
    Monés J; Biarnés M;
    Eur J Ophthalmol; 2020 Sep; 30(5):1082-1090. PubMed ID: 31088111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Vascular Endothelial Growth Factor Resistance in Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Kokame GT; deCarlo TE; Kaneko KN; Omizo JN; Lian R
    Ophthalmol Retina; 2019 Sep; 3(9):744-752. PubMed ID: 31511169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retention of good visual acuity in eyes with neovascular age-related macular degeneration and chronic refractory subfoveal subretinal fluid.
    Bhavsar KV; Freund KB
    Saudi J Ophthalmol; 2014 Apr; 28(2):129-33. PubMed ID: 24843306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal ranibizumab and bevacizumab therapy for choroidal neovascularization in age-related macular degeneration with extensive pre-existing geographic atrophy.
    Amaro MH; Roller AB
    Arq Bras Oftalmol; 2012; 75(4):273-6. PubMed ID: 23258660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neovascular Remodeling and Subretinal Fibrosis as Biomarkers for Predicting Incomplete Response to Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration.
    Wu J; Zhang J
    Front Biosci (Landmark Ed); 2022 Apr; 27(4):135. PubMed ID: 35468694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab.
    Patel KH; Chow CC; Rathod R; Mieler WF; Lim JI; Ulanski LJ; Leiderman YI; Arun V; Chau FY
    Eye (Lond); 2013 May; 27(5):663-7; quiz 668. PubMed ID: 23558214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab.
    Nudleman E; Wolfe JD; Woodward MA; Yonekawa Y; Williams GA; Hassan TS
    Clin Ophthalmol; 2016; 10():1053-7. PubMed ID: 27354759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration.
    Sridhar J; Hsu J; Shahlaee A; Garg SJ; Spirn MJ; Fineman MS; Vander J
    JAMA Ophthalmol; 2016 Apr; 134(4):437-43. PubMed ID: 26914218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy.
    Ogasawara M; Koizumi H; Yamamoto A; Itagaki K; Saito M; Maruko I; Okada AA; Iida T; Sekiryu T
    Jpn J Ophthalmol; 2018 Sep; 62(5):584-591. PubMed ID: 29974277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography.
    Abri Aghdam K; Seidensticker F; Pielen A; Framme C; Junker B
    Lasers Surg Med; 2016 Sep; 48(7):668-77. PubMed ID: 27111455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
    Steinle NC; Du W; Gibson A; Saroj N
    Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Neovascular Pachychoroid Disease Mimicking Exudative Age-Related Macular Degeneration.
    Kaseewat T; Phasukkijwatana N
    J Curr Ophthalmol; 2021; 33(1):82-87. PubMed ID: 34084962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central Serous Chorioretinopathy in Elderly Patients Mimicking Occult Neovascular Age-Related Macular Degeneration.
    Adrean SD; Chaili S; Pirouz A; Grant S
    Clin Ophthalmol; 2020; 14():4073-4078. PubMed ID: 33268981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and visual outcomes of non-resolving subretinal fluid in neovascular AMD despite continuous monthly anti-VEGF injections: a long-term follow-up.
    Hosseini H; Rabina G; Pettenkofer M; Au A; Chehaibou I; Heilweil G; Weiner AJ; Ip M; Loewenstein A; Schwartz SD
    Graefes Arch Clin Exp Ophthalmol; 2021 May; 259(5):1153-1160. PubMed ID: 33245430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choroidal neovascularization following argon laser photocoagulation for central serous chorioretinopathy.
    Fekih O; Mabrouk S; Zgolli MH; Bakir K; Zghal I; Nacef L
    Tunis Med; 2019 Jan; 97(1):157-162. PubMed ID: 31535710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Switching from ranibizumab to aflibercept in choroidal neovascularization secondary to angioid streaks.
    Sekfali R; Mimoun G; Cohen SY; Querques G; Bandello F; Sacconi R; Souied EH; Capuano V
    Eur J Ophthalmol; 2020 May; 30(3):550-556. PubMed ID: 30880436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-VEGF-refractory exudative age-related macular degeneration: differential response according to features on optical coherence tomography.
    Shin JY; Woo SJ; Ahn J; Park KH
    Korean J Ophthalmol; 2013 Dec; 27(6):425-32. PubMed ID: 24311928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness of anti-VEGF therapy for neovascular age-related macular degeneration in different types of exudative fluid localization].
    Budzinskaya MV; Afanasyeva MA; Plyukhova AA; Novikov IA; Shelankova AV; Andreeva IV
    Vestn Oftalmol; 2021; 137(6):12-17. PubMed ID: 34965062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Short-Term Choroidal Thickness and Retinal Morphological Changes after Intravitreal Anti-VEGF Therapy with Ranibizumab or Aflibercept in Treatment-Naive Eyes.
    Gharbiya M; Giustolisi R; Marchiori J; Bruscolini A; Mallone F; Fameli V; Nebbioso M; Abdolrahimzadeh S
    Curr Eye Res; 2018 Mar; 43(3):391-396. PubMed ID: 29166140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal Ziv-Aflibercept in Treatment of Naïve Chronic Central Serous Chorioretinopathy Related Choroidal Neovascular Membrane.
    Radke N; Kalamkar C; Mukherjee A; Radke S
    Case Rep Ophthalmol Med; 2017; 2017():5036248. PubMed ID: 29479487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.